This approval adds to Granules India's existing 67 ANDA approvals from the US FDA, strengthening its position in regulated ...

Since USP requires a class A container for unit dose packaging (i.e., a container that allows not more than 0.5 mg of moisture adsorption per day) and since PVC offers little or no barrier to ...

The USP Subcommittee on Packaging ... thereby exposing the pharmaceutical article to ambient atmospheric conditions. This exposure, and the fact that containers into which dosage forms are ...

Thefirst United States Pharmacopœia appeared in 1820, and up to 1936 revisions appeared at intervals of about ten years. This interval has now been reduced to five years, owing to the rapid ...

Granules India announced today that the U.S. Food & Drug Administration (USFDA) has approved the Abbreviated New Drug Application (ANDA) for Bupropion Hydrochloride Extended-Release Tablets USP (SR) ...

Granules India has received USFDA approval to market a generic medication for major depressive disorder, Bupropion ...

Bupropion hydrochloride extended-release tablets are widely prescribed for the treatment of major depressive disorder and for ...

The global pharmaceutical industry is growing and offers an attractive opportunity for investors. Well-established pharmaceutical stocks include AbbVie, Eli Lilly, Johnson & Johnson, and Pfizer.

On-dose authentication solution promises more direct and foolproof methods of assuring medicines authenticity.

Granules Pharmaceuticals, Inc., a 100% foreign subsidiary of Granules India received the U.S. Food & Drug Administration (USFDA) approval for abbreviated new drug application (ANDA) of Bupropion ...

Lupin Limited launches generic Pred Forte in the U.S., securing 180-day exclusivity, strengthening ophthalmic portfolio.

Global pharma major Lupin Limited (Lupin) announced the launch of the first generic version of Pred Forte (prednisolone acetate) ophthalmic suspension USP, 1% in the United States. Being the first ...